Omega Therapeutics logo

OMGA

Omega Therapeutics

$2.39

Earnings Summary

Revenue
$0.99Mn
Net Profits
$-20.21Mn
Net Profit Margins
-2043.88%

Highlights

Revenue:

Omega Therapeutics’s revenue jumped 34.56% since last year same period to $0.99Mn in the Q4 2023. On a quarterly growth basis, Omega Therapeutics has generated 19.01% jump in its revenue since last 3-months.

Net Profits:

Omega Therapeutics’s net profit jumped 34.12% since last year same period to $-20.21Mn in the Q4 2023. On a quarterly growth basis, Omega Therapeutics has generated 9.14% jump in its net profits since last 3-months.

Net Profit Margins:

Omega Therapeutics’s net profit margin jumped 51.04% since last year same period to -2043.88% in the Q4 2023. On a quarterly growth basis, Omega Therapeutics has generated 23.66% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Omega Therapeutics post its latest quarter earnings

EPS Estimate Current Quarter
-0.45
EPS Estimate Current Year
-0.45

Highlights

EPS Estimate Current Quarter:

Omega Therapeutics’s earning per share (EPS) estimates for the current quarter stand at -0.45 - a 0.56% jump from last quarter’s estimates.

EPS Estimate Current Year:

Omega Therapeutics’s earning per share (EPS) estimates for the current year stand at -0.45.

Key Ratios

Key ratios of the Omega Therapeutics post its Q1 2024 earnings

Earning Per Share (EPS)
0

Highlights

Earning Per Share (EPS):

Omega Therapeutics’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Omega Therapeutics has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-02
-0.45
0
100%